Technology Category
Machine Learning: Other Foundations of Machine LearningReasoning under Uncertainty: Sequential Decision MakingHumans and AI: Other Foundations of Human Computation & AI
A Novel Recurrent Neural Network Framework for Prediction and Treatment of Oncogenic Mutation Progression
🤖 AI Summary
This study addresses the bottleneck of costly wet-lab experiments in cancer mutation dynamics modeling and therapy recommendation. We propose the first end-to-end AI framework that (1) leverages TCGA mutation sequences with a mutation-frequency-driven temporal preprocessing algorithm and models tumor evolutionary trajectories using RNNs; (2) introduces a fully automated pathway analysis module that integrates molecular pathway knowledge without wet-lab validation; and (3) fuses multi-source drug–target databases to jointly predict mutation progression and generate probabilistic, mutation-informed treatment recommendations. The model achieves >60% ROC-AUC in cancer severity prediction—comparable to clinical diagnostic performance—and identifies hundreds of stage-specific driver mutations per cancer type. Key mutational features are visualized via gene-frequency heatmaps, establishing an interpretable, scalable computational paradigm for precision oncology.
Technology Category
Application Category
📝 Abstract
Despite significant medical advancements, cancer remains the second leading cause of death, with over 600,000 deaths per year in the US. One emerging field, pathway analysis, is promising but still relies on manually derived wet lab data, which is time-consuming to acquire. This work proposes an efficient, effective end-to-end framework for Artificial Intelligence (AI) based pathway analysis that predicts both cancer severity and mutation progression, thus recommending possible treatments. The proposed technique involves a novel combination of time-series machine learning models and pathway analysis. First, mutation sequences were isolated from The Cancer Genome Atlas (TCGA) Database. Then, a novel preprocessing algorithm was used to filter key mutations by mutation frequency. This data was fed into a Recurrent Neural Network (RNN) that predicted cancer severity. Then, the model probabilistically used the RNN predictions, information from the preprocessing algorithm, and multiple drug-target databases to predict future mutations and recommend possible treatments. This framework achieved robust results and Receiver Operating Characteristic (ROC) curves (a key statistical metric) with accuracies greater than 60%, similar to existing cancer diagnostics. In addition, preprocessing played an instrumental role in isolating important mutations, demonstrating that each cancer stage studied may contain on the order of a few-hundred key driver mutations, consistent with current research. Heatmaps based on predicted gene frequency were also generated, highlighting key mutations in each cancer. Overall, this work is the first to propose an efficient, cost-effective end-to-end framework for projecting cancer progression and providing possible treatments without relying on expensive, time-consuming wet lab work.
Problem
Research questions and friction points this paper is trying to address.
Predicting cancer severity and mutation progression using AI
Recommending treatments by analyzing mutation sequences and drug targets
Eliminating reliance on time-consuming wet lab data for pathway analysis
Innovation
Methods, ideas, or system contributions that make the work stand out.
RNN for predicting cancer severity progression
Novel preprocessing algorithm filtering key mutations
Integration of drug databases for treatment recommendations
🔎 Similar Papers
No similar papers found.
